# Clinical Trial on Binge Eating Disorder, Treatment With Naloxone Spray

> **NCT01567670** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Lightlake Sinclair Ltd.** · enrollment: 138 (estimated)

## Conditions studied

- Binge Eating Disorder

## Interventions

- **DRUG:** Naloxone
- **DRUG:** naloxone placebo

## Key facts

- **NCT ID:** NCT01567670
- **Lead sponsor:** Lightlake Sinclair Ltd.
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-08
- **Primary completion:** 2012-06
- **Final completion:** —
- **Target enrollment:** 138 (ESTIMATED)
- **Last updated:** 2012-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01567670

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01567670, "Clinical Trial on Binge Eating Disorder, Treatment With Naloxone Spray". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01567670. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*